Parotid sparing and quality of life in long-term survivors of locally advanced head and neck cancer after intensity-modulated radiation therapy

https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf. Accessed 5 September 2020 Jabbari S et al (2005) Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report. Int J Radiat Oncol Biol Phys 63(3):725–731 Jellema AP et al (2007) Impact of radiation-induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer. Int J Radiat Oncol Biol Phys 69(3):751–760 Abel E et al (2017) Impact on quality of life of IMRT versus 3‑D conformal radiation therapy in head and neck cancer patients: a case control study. Adv Radiat Oncol 2(3):346–353 Nutting CM et al (2011) Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 12(2):127–136 Jensen SB et al (2019) Salivary gland hypofunction and xerostomia in head and neck radiation patients. J Natl Cancer Inst Monogr 2019(53):lgz016. https://doi.org/10.1093/jncimonographs/lgz016 Tribius S et al (2015) Residual deficits in quality of life one year after intensity-modulated radiotherapy for patients with locally advanced head and neck cancer. Strahlenther Onkol 191(6):501–510 Mogadas S et al (2020) Influence of radiation dose to pharyngeal constrictor muscles on late dysphagia and quality of life in patients with locally advanced oropharyngeal carcinoma. Strahlenther Onkol 196(6):522–529 Little M et al (2012) Reducing xerostomia after chemo-IMRT for head-and-neck cancer: beyond sparing the parotid glands. Int J Radiat Oncol Biol Phys 83(3):1007–1014 Tribius S et al (2013) Xerostomia after radiotherapy. What matters—Mean total dose or dose to each parotid gland? Strahlenther Onkol 189(3):216–222 Roesink JM et al (2005) A comparison of mean parotid gland dose with measures of parotid gland function after radiotherapy for head-and-neck cancer: implications for future trials. Int J Radiat Oncol Biol Phys 63(4):1006–1009 Eisbruch A et al (1999) Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 45(3):577–587 Deasy JO et al (2010) Radiotherapy dose-volume effects on salivary gland function. Int J Radiat Oncol Biol Phys 76(3 Suppl):S58–S63 Price RE et al (1995) Effects of continuous hyperfractionated accelerated and conventionally fractionated radiotherapy on the parotid and submandibular salivary glands of rhesus monkeys. Radiother Oncol 34(1):39–46 Lombaert IM et al (2008) Rescue of salivary gland function after stem cell transplantation in irradiated glands. PLoS ONE 3(4):e2063 Hawkins PG et al (2018) Sparing all salivary glands with IMRT for head and neck cancer: longitudinal study of patient-reported xerostomia and head-and-neck quality of life. Radiother Oncol 126(1):68–74 Jellema AP et al (2007) Unilateral versus bilateral irradiation in squamous cell head and neck cancer in relation to patient-rated xerostomia and sticky saliva. Radiother Oncol 85(1):83–89 Sommat K et al (2019) Clinical and dosimetric predictors of physician and patient reported xerostomia following intensity modulated radiotherapy for nasopharyngeal cancer—A prospective cohort analysis. Radiother Oncol 138:149–157 Teng F et al (2019) Reducing xerostomia by comprehensive protection of salivary glands in intensity-modulated radiation therapy with helical tomotherapy technique for head-and-neck cancer patients: a prospective observational study. Biomed Res Int 2019:2401743 Bernier J, Vermorken JB, Koch WM (2006) Adjuvant therapy in patients with resected poor-risk head and neck cancer. J Clin Oncol 24(17):2629–2635 Cooper JS et al (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350(19):1937–1944 Cooper JS et al (2012) Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 84(5):1198–1205 Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31(5):1341–1346 N.A. (1995) LENT SOMA scales for all anatomic sites. Int J Radiat Oncol Biol Phys 31(5):1049–1091 Rubin P et al (1995) EORTC Late Effects Working Group. Overview of late effects normal tissues (LENT) scoring system. Radiother Oncol 35(1):9–10 Rubin P et al (1995) RTOG Late Effects Working Group. Overview. Late Effects of Normal Tissues (LENT) scoring system. Int J Radiat Oncol Biol Phys 31(5):1041–1042 Aaronson NK et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376 Bjordal K et al (1994) Development of a European Organization for Research and Treatment of Cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patients. EORTC Quality of Life Study Group. Acta Oncol 33(8):879–885 Fayers PM, Aaronson N, Bjordal K, EORTC Quality of Life Study Group, - (2001) The EORTC QLQ-C30 scoring manual, 3rd edn. European Organisation for Research and Treatment of Cancer, Brussels King MT (1996) The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 5(6):555–567 Giesinger JM et al (2020) Thresholds for clinical importance were defined for the European organisation for research and treatment of cancer computer adaptive testing core-an adaptive measure of core quality of life domains in oncology clinical practice and research. J Clin Epidemiol 117:117–125 Arraras JI et al (2002) The EORTC QLQ-C30 (version 3.0) quality of life questionnaire: validation study for Spain with head and neck cancer patients. Psychooncology 11(3):249–256 Singer S et al (2013) Performance of the EORTC questionnaire for the assessment of quality of life in head and neck cancer patients EORTC QLQ-H&N35: a methodological review. Qual Life Res 22(8):1927–1941 Singer S et al (2009) Validation of the EORTC QLQ-C30 and EORTC QLQ-H&N35 in patients with laryngeal cancer after surgery. Head Neck 31(1):64–76 Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Academic Press, New York Osoba D et al (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16(1):139–144 King AJ et al (2015) Prostate cancer and supportive care: a systematic review and qualitative synthesis of men’s experiences and unmet needs. Eur J Cancer Care (Engl) 24(5):618–634 Paterson C et al (2017) Unmet supportive care needs of men with locally advanced and metastatic prostate cancer on hormonal treatment: a mixed methods study. Cancer Nurs 40(6):497–507 Moore HCF (2020) Breast cancer survivorship. Semin Oncol 47(4):222–228 Koh J et al (2019) Head and neck squamous cell carcinoma survivorship care. Aust J Gen Pract 48(12):846–848 Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. https://acsjournals.onlinelibrary.wiley.com/doi/pdf/10.3322/caac.21492. Accessed 31 August 2020 Bjordal K, Mastekaasa A, Kaasa S (1995) Self-reported satisfaction with life and physical health in long-term cancer survivors and a matched control group. Eur J Cancer B Oral Oncol 31B(5):340–345 Pow EH et al (2006) Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 66(4):981–991 Vergeer MR et al (2009) Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program. Int J Radiat Oncol Biol Phys 74(1):1–8 Ringash J et al (2005) Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia. Int J Radiat Oncol Biol Phys 61(5):1403–1407 Hunter KU et al (2013) Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: prospective study of patient-reported, observer-rated, and objective outcomes. Int J Radiat Oncol Biol Phys 85(4):935–940 Richards TM et al (2017) The effect of parotid gland-sparing intensity-modulated radiotherapy on salivary composition, flow rate and xerostomia measures. Oral Dis 23(7):990–1000 Elting LS et al (2008) Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life. Cancer 113(10):2704–2713 Tribius S et al (2012) Global quality of life during the acute toxicity phase of multimodality treatment for patients with head and neck cancer: can we identify patients most at risk of profound quality of life decline? Oral Oncol 48(9):898–904 Jellema AP et al (2005) Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy? Radiother Oncol 77(2):164–171 Meirovitz A et al (2006) Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer. Int J Radiat Oncol Biol Phys 66(2):445–453 Meyer F et al (2012) Predictors of severe acute and late toxicities in patients with localized head-and-neck cancer treated with radiation therapy. Int J Radiat Oncol Biol Phys 82(4):1454–1462 El-Deiry MW et al (2009) Influences and predictors of long-term quality of life in head and neck cancer survivors. Arch Otolaryngol Head Neck Surg 135(4):380–384 Funk GF, Karnell LH, Christensen AJ (2012) Long-term health-related quality of life in survivors of head and neck cancer. Arch Otolaryngol Head Neck Surg 138(2):123–133 Scrimger R et al (2007) Correlation between saliva production and quality of life measurements in head and neck cancer patients treated with intensity-modulated radiotherapy. Am J Clin Oncol 30(3):271–277 Beetz I et al (2014) The QUANTEC criteria for parotid gland dose and their efficacy to prevent moderate to severe patient-rated xerostomia. Acta Oncol 53(5):597–604 Robbins KT (1992) Head and neck oncology. Otolaryngol Head Neck Surg 106(1):7–8 Veldeman L et al (2008) Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies. Lancet Oncol 9(4):367–375 Massa ST et al (2019) Comparison of the financial burden of survivors of head and neck cancer with other cancer survivors. JAMA Otolaryngol Head Neck Surg 145(3):239–249 Tribius S et al (2018) Socioeconomic status and quality of life in patients with locally advanced head and neck cancer. Strahlenther Onkol 194(8):737–749 Buettner M et al (2019) Out-of-pocket-payments and the financial burden of 502 cancer patients of working age in Germany: results from a longitudinal study. Support Care Cancer 27(6):2221–2228 Koch R et al (2015) Employment pathways and work-related issues in head and neck cancer survivors. Head Neck 37(4):585–593 Giesinger JM, Loth FLC, Aaronson NK et al (2020) Thresholds for clinical importance were defined for the European organisation for research and treatment of cancer computer adaptive testing core-an adaptive measure of core quality of life domains in oncology clinical practice and research. J Clin Epidemiol 117:117–125